Sabra Healthcare REIT, Inc. (SBRA) is a publicly traded Real Estate sector company. As of May 21, 2026, SBRA trades at $21.03 with a market cap of $5.28B and a P/E ratio of 33.39. SBRA moved +0.19% today. Year to date, SBRA is +10.38%; over the trailing twelve months it is +16.55%. Its 52-week range spans $15.60 to $21.28. Analyst consensus is buy with an average price target of $22.33. Rallies surfaces SBRA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Sabra Healthcare REIT, Inc. (SBRA) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. SBRA moved +0.19% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $21.03 |
| Market Cap | $5.28B |
| P/E Ratio | 33.39 |
| EPS | $0.63 |
| Dividend Yield | 0.30% |
| 52-Week High | $21.28 |
| 52-Week Low | $15.60 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $812.84M |
| Net Income | $156.02M |
| Gross Margin | 0.00% |
7 analysts cover SBRA: 0 strong buy, 2 buy, 5 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $22.33.